Cargando...

Ticagrelor-Induced Prolongation of the QTc Interval

BACKGROUND: Ticagrelor has been accepted as a class I antiplatelet agent in patients undergoing percutaneous coronary angioplasty (PTCA). There have been cases reported on ticagrelor being associated with various cardiac conduction defects. But there is no evidence of QTc prolongation associated wit...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Case Rep Cardiol
Main Authors: Ray, Avik, Najmi, Ahmad, Khandelwal, Gaurav, Sadasivam, Balakrishnan
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi 2019
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6881594/
https://ncbi.nlm.nih.gov/pubmed/31827937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/5984847
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!